AcelRx Pharmaceuticals Inc. News
Here's Why AcelRx Pharmaceuticals (ACRX) Stock Gained Today
AcelRx Pharmaceuticals (ACRX) announced on Thursday that ARX-04, its experimental pain relief drug, had positive results in a phase III clinical trial.
AcelRx Pharmaceuticals (ACRX) Highlighted As Weak On High Volume
Trade-Ideas LLC identified AcelRx Pharmaceuticals (ACRX) as a weak on high relative volume candidate
AcelRx Pharmaceuticals (ACRX) Strong On High Relative Volume Today
Trade-Ideas LLC identified AcelRx Pharmaceuticals (ACRX) as a strong on high relative volume candidate
Amicus, Other Biotech CEOs Should Listen More, Talk Less About FDA Matters
There's a valuable, albeit painful, lesson here in Amicus' blow-up. Biotech CEOs should shut their mouths about regulatory plans until they receive definitive word from the FDA.
5 Stocks Poised for Breakouts
These stocks look ready to break out and trade higher from current levels.
Ford Makes a Major Change
The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.
Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll
Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.
Coinbase Faces A New Scandal
The platform denies selling proprietary customer data and announces it is expanding into several European countries.